13D/13G Filings - Travere Therapeutics Inc. (TVTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-09
10:33 am
Purchase
2023-12-31 13G Travere Therapeutics, Inc.
TVTX
MORGAN STANLEY
MS
4,152,446
5.500%
4,152,446increase
(New Position)
Filing
History
2024-02-07
07:37 am
Sale
2023-12-31 13G Travere Therapeutics, Inc.
TVTX
ADAGE CAPITAL PARTNERS GP L.L.C. 500,000
0.670%
-3,918,962decrease
(-88.69%)
Filing
History
2024-01-25
09:24 am
Purchase
2023-12-31 13G Travere Therapeutics, Inc.
TVTX
STATE STREET CORP
STT
5,352,345
7.120%
1,128,321increase
(+26.71%)
Filing
History
2024-01-24
09:46 am
Purchase
2023-12-31 13G Travere Therapeutics, Inc.
TVTX
BlackRock Inc.
BLK
7,990,020
10.600%
287,792increase
(+3.74%)
Filing
History
2023-10-06
2:34 pm
Purchase
2023-09-30 13G Travere Therapeutics, Inc.
TVTX
BlackRock Inc.
BLK
7,702,228
10.300%
2,507,443increase
(+48.27%)
Filing
History
2023-05-15
5:02 pm
Sale
2023-05-15 13G Travere Therapeutics, Inc.
TVTX
RA Capital Management, L.P. 0
0.000%
-3,984,681decrease
(Position Closed)
Filing
History
2023-03-13
4:30 pm
Purchase
2023-03-01 13G Travere Therapeutics, Inc.
TVTX
ADAGE CAPITAL PARTNERS GP L.L.C. 4,418,962
5.940%
1,818,962increase
(+69.96%)
Filing
History
2023-02-14
4:45 pm
Sale
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
RA Capital Management, L.P. 3,984,681
6.200%
-1,629,747decrease
(-29.03%)
Filing
History
2023-02-14
3:22 pm
Sale
2022-12-30 13G Travere Therapeutics, Inc.
TVTX
Macquarie Group Limited 3,555,992
5.540%
-211,900decrease
(-5.62%)
Filing
History
2023-02-14
1:39 pm
Purchase
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
Armistice Capital, LLC 6,412,000
9.990%
2,334,000increase
(+57.23%)
Filing
History
2023-02-14
08:59 am
Purchase
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
Deep Track Capital, LP 4,582,000
7.140%
1,146,800increase
(+33.38%)
Filing
History
2023-02-10
5:27 pm
Sale
2022-12-30 13G Travere Therapeutics, Inc.
TVTX
GOLDMAN SACHS GROUP INC
GS
3,142,175
4.900%
-1,457,104decrease
(-31.68%)
Filing
History
2023-02-10
11:50 am
Purchase
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
JANUS HENDERSON GROUP PLC
JHG
5,091,285
7.900%
1,075,127increase
(+26.77%)
Filing
History
2023-02-09
11:35 am
Sale
2022-12-30 13G Travere Therapeutics, Inc.
TVTX
The Vanguard Group 3,515,446
5.480%
-365,427decrease
(-9.42%)
Filing
History
2023-02-09
11:04 am
Sale
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
ADAGE CAPITAL PARTNERS GP L.L.C. 2,600,000
4.050%
-1,327,000decrease
(-33.79%)
Filing
History
2023-02-06
2:55 pm
Purchase
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
STATE STREET CORP
STT
4,224,024
6.580%
4,224,024increase
(New Position)
Filing
History
2023-02-03
4:27 pm
Purchase
2022-12-31 13G Travere Therapeutics, Inc.
TVTX
BlackRock Inc.
BLK
5,194,785
8.100%
679,640increase
(+15.05%)
Filing
History
2022-10-28
4:30 pm
Purchase
2022-10-18 13G Travere Therapeutics, Inc.
TVTX
ADAGE CAPITAL PARTNERS GP L.L.C. 3,927,000
6.140%
2,624,508increase
(+201.50%)
Filing
History
2022-05-16
4:55 pm
Purchase
2022-05-06 13G Travere Therapeutics, Inc.
TVTX
Deep Track Capital, LP 3,435,200
5.410%
985,200increase
(+40.21%)
Filing
History
2022-02-14
5:22 pm
Purchase
2021-12-31 13G Travere Therapeutics, Inc.
TVTX
Armistice Capital, LLC 4,078,000
6.700%
4,078,000increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, Next